AEGR
Barclays’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,598
| Closed | -$5K | – | 4169 |
|
|
2016
Q3 | $5K | Sell |
1,598
-2,082
| -57% | -$6.51K | ﹤0.01% | 3443 |
|
|
2016
Q2 | $6K | Sell |
3,680
-2,527
| -41% | -$4.12K | ﹤0.01% | 3111 |
|
|
2016
Q1 | $18K | Sell |
6,207
-20,614
| -77% | -$59.8K | ﹤0.01% | 2822 |
|
|
2015
Q4 | $268K | Buy |
26,821
+17,491
| +187% | +$175K | ﹤0.01% | 1919 |
|
|
2015
Q3 | $122K | Buy |
9,330
+8,346
| +848% | +$109K | ﹤0.01% | 2301 |
|
|
2015
Q2 | $17K | Sell |
984
-25,490
| -96% | -$440K | ﹤0.01% | 3063 |
|
|
2015
Q1 | $688K | Sell |
26,474
-213,253
| -89% | -$5.54M | ﹤0.01% | 1758 |
|
|
2014
Q4 | $4.8M | Sell |
239,727
-93,632
| -28% | -$1.87M | ﹤0.01% | 939 |
|
|
2014
Q3 | $11M | Sell |
333,359
-37,504
| -10% | -$1.24M | 0.01% | 605 |
|
|
2014
Q2 | $11.9M | Buy |
370,863
+118,556
| +47% | +$3.79M | 0.01% | 566 |
|
|
2014
Q1 | $11.6M | Sell |
252,307
-10,674
| -4% | -$491K | 0.01% | 609 |
|
|
2013
Q4 | $18.4M | Buy |
262,981
+48,367
| +23% | +$3.39M | 0.02% | 476 |
|
|
2013
Q3 | $18.2M | Buy |
214,614
+130,490
| +155% | +$11.1M | 0.02% | 390 |
|
|
2013
Q2 | $5.33M | Buy |
+84,124
| New | +$5.33M | 0.01% | 826 |
|